BRAIN RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2023-05-15 121ccd8dm34(暂无昵称)

各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？

47 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2023-08-17 ms3000001512295561 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：神经行为学;糖尿病
经验分享：2023.08.06 投稿
2023.08.07 Received by Editor
2023.08.17 Received by Editor
好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏

40 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2021-09-27 Jason2021

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经科学;神经保护;行为学研究
经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online

81 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2022-01-23 ms4000000145395898

各位战友：
submit 2022-1-10
in reviewer agreement 2022-1-10
reviews complete 2022-1-23
请问一下什么时候可以出一审意见啊？希望有好运🍀

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2022-02-28 ms6000000748407215

偏重的研究方向：fMRI
经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2023-05-27 ms5000001864785048 来自广西

偏重的研究方向：fMRI
经验分享：请问大家in reviewer agreement多久可以发邮件问问啊

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2018-05-16 1229d752m68暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5
感觉这个要看运气的

230 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2020-06-27 1212303bm54(暂无昵称)

投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久

120 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2022-10-14 ms1000000582200464

偏重的研究方向：肿瘤
经验分享：脑癌可以投稿这个杂质吗

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友： submit 2022-1-10 in reviewer agreement 2022-1-10 reviews complete 2022-1-23 请问一下什么时候可以出一审意见啊？希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197950, encodeId=a461119e9504e, content=偏重的研究方向：fMRI 经验分享：各位战友，我投了之后一直显示received by editor，两周了要不要发邮件问问😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21fd6146310, createdName=ms6000000748407215, createdTime=Mon Feb 28 10:00:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=556101, encodeId=47e75561013e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：我的比较慢，一共审了三轮，从2017.9-2018.5 感觉这个要看运气的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c2345502, createdName=1229d752m68暂无昵称, createdTime=Wed May 16 13:26:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800027, encodeId=dab380002eab, content=投了将近两周的时间还是received by editor 不知道是不是受疫情影响有没有投过的老师们知道这个投稿周期大概有多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6kBwGFGZfUCAz579KfQIDHQwv4FhHwu3zOGl2gFvIDXD8QJeLHNWUOicDjicbKjLD9S0H0OK5zsvA/132, createdBy=0f912231030, createdName=1212303bm54(暂无昵称), createdTime=Sat Jun 27 15:50:22 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省)]

2023-09-25 ms9000000940325280 来自湖北省

审稿速度:1.0
经验分享：还行

34 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务